Showing results (331-340 of 653) with videos related to

Sort By:
Pageof 66
Cancer|September 25, 2004
Contralateral prophylactic mastectomy. Predictors of significant histologic findingsKatja Goldflam, Kelly K Hunt, Jeffrey E Gershenwald, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|May 21, 2021
Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV TrialPuneet Singh, Marion E Scoggins, Aysegul A Sahin, et al.
Scientific Reports|March 13, 2021
Associations between the gut microbiome and fatigue in cancer patientsJoud Hajjar, Tito Mendoza, Liangliang Zhang, et al.
Molecular Cancer Therapeutics|May 7, 2009
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumorChangye Y Zou, Kerrington D Smith, Quan-Sheng Zhu, et al.
Annals of Surgical Oncology|November 9, 2016
Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary TherapyElizabeth FitzSullivan, Roland L Bassett, Henry M Kuerer, et al.
Cancer|February 26, 2013
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017Jennifer F De Los Santos, Alan Cantor, Keith D Amos, et al.
Clinical Breast Cancer|April 28, 2015
Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast CancerAna M Gonzalez-Angulo, Xiudong Lei, Richardo H Alvarez, et al.
Annals of Surgical Oncology|February 8, 2006
Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsyLaura A Lambert, Gregory D Ayers, Rosa F Hwang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodesThomas A Buchholz, Wendy A Woodward, Zhigang Duan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitorsFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Pageof 66